Menogaril
Names | |
---|---|
Other names
7-O-Methylnogarol | |
Identifiers | |
71628-96-1 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL1234391 |
ChemSpider | 4450900 |
PubChem | 5288818 |
UNII | 8JSV4O30HQ |
| |
| |
Properties | |
C28H31NO10 | |
Molar mass | 541.55 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Menogaril is an anthracycline analog of nogalamycin which was developed in late 1970s. It has even stronger anticancer activity than nogalamycin and has less toxicity than nogalamycin. However, its development for clinical use was cancelled.[1]
References
- ↑ Moore DF Jr; Brown TD; LeBlanc M; Dahlberg S; Miller TP; McClure S; Fisher RI. (1999). "Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trial.". Invest New Drugs. 17 (2): 169–72. doi:10.1023/A:1006375301205.
This article is issued from Wikipedia - version of the 6/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.